ESR1 and breast carcinoma: We and others have described a double-negative feedback loop involving E2-suppressed microRNAs that target ERα, specifically miR-206 and miR-221&222, resulting in upregulation of ERα expression and low miRNA level in luminal A-type breast cancers [17], [21].